Page last updated: 2024-10-26

etodolac and Postoperative Complications

etodolac has been researched along with Postoperative Complications in 3 studies

Etodolac: A non-steroidal anti-inflammatory agent and cyclooxygenase-2 (COX-2) inhibitor with potent analgesic and anti-arthritic properties. It has been shown to be effective in the treatment of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; and in the alleviation of postoperative pain (PAIN, POSTOPERATIVE).
etodolac : A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active.

Postoperative Complications: Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.

Research Excerpts

ExcerptRelevanceReference
"When tumors reached 100 mm, mice were treated with CpG-C/vehicle, and 24 hours later the tumor was excised along with P+E/vehicle treatment."1.37Improving postoperative immune status and resistance to cancer metastasis: a combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses. ( Ben-Eliyahu, S; Benish, M; Goldfarb, Y; Levi, B; Melamed, R; Sorski, L, 2011)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Glasner, A1
Avraham, R1
Rosenne, E1
Benish, M3
Zmora, O2
Shemer, S1
Meiboom, H1
Ben-Eliyahu, S3
Goldfarb, Y1
Sorski, L2
Levi, B2
Melamed, R1
Hazut, O1
Shaashua, L1
Benjamin, B1
Hoffman, A1

Other Studies

3 other studies available for etodolac and Postoperative Complications

ArticleYear
Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor.
    Journal of immunology (Baltimore, Md. : 1950), 2010, Mar-01, Volume: 184, Issue:5

    Topics: Adrenergic beta-Antagonists; Amputation, Surgical; Animals; Antineoplastic Combined Chemotherapy Pro

2010
Improving postoperative immune status and resistance to cancer metastasis: a combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses.
    Annals of surgery, 2011, Volume: 253, Issue:4

    Topics: Analysis of Variance; Animals; Chemotherapy, Adjuvant; Disease Models, Animal; Etodolac; Female; Imm

2011
The effect of β-adrenergic blockade and COX-2 inhibition on healing of colon, muscle, and skin in rats undergoing colonic anastomosis.
    International journal of clinical pharmacology and therapeutics, 2011, Volume: 49, Issue:9

    Topics: Abdominal Wall; Adrenergic beta-Antagonists; Anastomosis, Surgical; Animals; Colon; Cyclooxygenase 2

2011